Show an ad over header. AMP

I am the FIRST!!!

47 senators call on McConnell to allow vote on John Lewis Voting Rights Advancement Act

Sen. Patrick Leahy (D-Vt.) introduced a bill with the support of 46 co-sponsors on Wednesday that would fully restore the landmark Voting Rights Act of 1965 in the name of the late civil rights icon Rep. John Lewis (D-Ga.).

Why it matters: The John Lewis Voting Rights Advancement Act aims to counter the Supreme Court's controversial 2013 ruling in Shelby County v. Holder, which gutted voter protections that had required states with a history of racial discrimination to gain federal approval before changing voting laws.


  • Lewis, who passed away last Friday, fought his entire life to secure equal voting rights and did not live to see the Voting Rights Act restored.
  • The Senate bill named in his honor would also provide the federal government with "other critical tools to combat what has become a full-fledged assault on Americans’ right to vote," Leahy said in a statement.
  • The bill was co-sponsored by every Democratic senator and the two independents who caucus with Democrats, as well as Sen. Lisa Murkowski (R-Alaska)

The state of play: The Democratic-led House passed a similar bill to restore the Voting Rights Act in 2019, but Senate Majority Leader Mitch McConnell (R-Ky.) has declined to bring it up for a vote.

What they're saying: “John called voting ‘the most powerful nonviolent tool we have to create a more perfect union.’ He was right. And that’s why we cannot stand idly by while states engage in flagrant suppression schemes to take this tool away from marginalized communities," Leahy said in a speech on the Senate floor.

  • "The House already passed the companion to the John Lewis Voting Rights Advancement Act in December. Now we must do our part. We cannot claim to honor the life of John Lewis if we refuse to carry on his life’s work. Or worse, if we stand in the way of that work."

Go deeper: Jim Clyburn calls for Congress to pass John R. Lewis Voting Rights Act of 2020

regular 4 post ff

infinite scroll 4 pff

Cameo CEO says he would let Trump join platform

Cameo CEO Steven Galanis doesn't want the app he built to be used explicitly for politics, but said he would allow former President Trump on the platform.

  • "Trump has done nothing on our platform to violate our terms of service," Galanis says in an interview with "Axios on HBO" that aired Sunday.

Why it matters: Cameo's approach is different than some of its Big Tech peers.

Keep reading...Show less

Sanofi, GSK COVID vaccine shows strong immune response in phase 2 trials

Sanofi and GSK announcedthis morning their COVID-19 vaccine candidate demonstrated a strong immune response in adults in a phase 2 clinical trial.

Why it matters: Sanofi and GSK say their recombinant protein-based vaccine candidate could ultimately serve as a universal COVID-19 vaccine booster, able to boost immunity regardless of the vaccination first received.

Keep reading...Show less

"Starfield” is Microsoft’s blockbuster Xbox game for 2022

“Starfield,” the next big game from the makers of “Fallout” and “The Elder Scrolls” will be released on Nov. 11, 2022 for Xbox consoles and PC — and not for PlayStation, according to a new trailer.

Why it matters: “Starfield” is about as big as it gets in terms of upcoming blockbuster games and will likely be ace for Microsoft commercially.

Keep reading...Show less

New memos show how top FDA officials thought slim evidence was enough for Alzheimer drug approval

FDA statisticians did not believe experimental Alzheimer's treatment Aduhelm proved that it could slow down the cognitive disease, but the top brass at the agency thought there was enough evidence to approve the drug anyway, according to internal documents released by the FDA today.

Why it matters: Outside experts almost unanimously voted down the drug, and the scientific community has blasted the FDA's approval of Aduhelm. But FDA leaders repeatedly cited "the urgent and unmet medical need" for Alzheimer's treatments.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;